Silver Book Fact

1 and 6-month mortality rates without treatment for sSAS

Waiting for treatment for severe symptomatic aortic stenosis (sSAS) can be deadly, with 1-month mortality at 3.7% and 6-month mortality at 11.6% (measured from the time intervention was recommended).

Malaisrie C, McDonald E, Kruse J, Li Z, et al. Mortality While Waiting for Aortic Valve Replacement. The Annals of Thoracic Surgery. 2014; 98. http://www.annalsthoracicsurgery.org/article/S0003-4975(14)01324-1/pdf

Reference

Title
Mortality While Waiting for Aortic Valve Replacement
Publication
The Annals of Thoracic Surgery
Publication Date
2014
Authors
Malaisrie C, McDonald E, Kruse J, Li Z, et al.
URL
Read Full Resource

Categories

  • Cost of Disease
  • Human Burden

Connected Facts

Related Facts

  • Undertreatment of patients with sSAS
    AS is often undertreated — one study found that 56% of severe symptomatic aortic stenosis (sSAS) patients referred to a cardiothoracic surgeon were not operated on.  
  • Survival rates for patients with sSAS without repair or replacement
     
  • Increased hospital admissions and prolonged length of stay for patients who do not undergo treatment
    Medicare severe symptomatic aortic stenosis (sSAS) patients who do not undergo treatment have an average of 1.9 hospital admissions per year and prolonged lengths of stay — 11.5 hospital days…  
  • SAS patient hospitalization costs
    Symptomatic aortic stenosis (SAS) patients who do not undergo treatment cost Medicare as much as $1.3 billion each year due to rehospitalization, prolonged stays, admissions to skilled nursing facilities, and…  
  • 2016 prevalence of Americans 65+ who had AVD
    In 2016, an estimated 5.2 million U.S. adults ages 65+ had aortic valve disease (AVD).   Note: Alliance for Aging Research generated statistic, based on 2005 percentage prevalence estimates by Bach et al. 2007